Nav: Home

Loss of pericytes deteriorates retinal environment

May 16, 2017

Inside the eye, at the interface between blood vessels and the retina, lies a boundary that prevents harmful substances present in the blood from entering the retina. Researchers at the Center for Vascular Research, within the Institute for Basic Science (IBS) are studying the role of cells called pericytes, which protectively wrap the retinal vessels building up this blood-retinal barrier. This new study published in Nature Communications, revealed how the loss of pericytes aggravates the retinal environment and function in a mouse experimental model. These findings could contribute to the development of new therapies for blindness-causing diseases, such as diabetic eye disease (diabetic retinopathy).

Diabetic retinopathy, one of the major complications of diabetes, is considered a leading cause of blindness in adults. The loss of pericyte at the blood-retinal barrier is a hallmark of this disease, but its leading causes and exact roles are still unclear. "We still do not know how pericytes influence the development of diabetic retinopathy. Is the loss of pericytes the direct cause of this disease? Or the aftermath of other damages of the blood-retinal barrier? Or both of them? Knowing this information can help us tackle the disease," explains KOH Gou Young, corresponding author of this study.

Diabetic retinopathy can affect patients who have had diabetes for around 10-20 years. On the other hand, studying this disease on mouse experimental models is difficult because of their short lifespan. IBS scientists produced a new mouse model to study diabetic retinopathy and observed that young mice deprived of the growth factor responsible for proper attachment of pericytes to retinal vessels had severe retinal vascular leakage, impaired vascular network and visual loss similar to diabetic retinopathy. The research team confirmed that at the heart of these symptoms is the lack of pericytes at the blood-retinal barrier.

Then, the researchers showed that pericytes play an important role in the vessels because they regulate a molecular pathway associated with vascular stabilization, which includes important proteins, such as Tie2, FOXO1, and Ang2. The loss of pericytes corresponds to the reduced production of Tie2, an essential protein for vascular stabilization, in par with the activation of FOXO1, which is responsible for the production of several proteins associated with vascular destabilization, such as Ang2. Ang2 inhibits the activity of Tie2, triggering a vicious cycle that increases deterioration of the retinal vascular environment and destroys the blood-retinal barrier.

IBS scientists then made a surprising observation: while young mice deprived of pericytes experienced such harmful effects, adult mice did not suffer from the same problems. Unexpectedly, when the scientists removed the pericytes from the retina of adult mice, the vessels kept resistant to vascular leakage. One thing the scientists could observe though, is that these adult healthy-looking retinas without pericytes were more sensitive to the vascular endothelial growth factor A (VEGF-A). VEGF-A causes the activation of FOXO1 and Ang2, leading to lesions that resembles diabetic retinopathy.

"The role of pericytes is still not fully understood, however these experiments show that once the blood-retinal barrier around the vessels is well established, as in adulthood, pericytes dropout is not the only cause of diabetic retinopathy. It is instead an aggravating factor that essentially accelerates the progression of the disease, sensitizes it to VEGF-A and further destabilizes retinal blood vessels," explains Koh. "We expect that the activation of Tie2, together with Ang2 inhibition could be used therapeutically to treat retinopathy."
-end-


Institute for Basic Science

Related Blood Vessels Articles:

When blood vessels are overly permeable
In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases.
Nicotine-free e-cigarettes can damage blood vessels
A Penn study reveals single instance of vaping immediately leads to reduced vascular function.
Creating blood vessels on demand
Researchers discover new cell population that can help in regenerative processes.
Self-sustaining, bioengineered blood vessels could replace damaged vessels in patients
A research team has bioengineered blood vessels that safely and effectively integrated into the native circulatory systems of 60 patients with end-stage kidney failure over a four-year phase 2 clinical trial.
Found: the missing ingredient to grow blood vessels
Researchers have discovered an ingredient vital for proper blood vessel formation that explains why numerous promising treatments have failed.
More Blood Vessels News and Blood Vessels Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...